FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/08/015453 [Registered on: 24/08/2018] Trial Registered Prospectively
Last Modified On: 03/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Other 
Public Title of Study   A clinical trial to study the efficacy of Ilaguseena chooranam for Venpadai 
Scientific Title of Study   An open clinical study to evaluate the clinical efficacy of siddha sasthric formulation Ilaguseena chooranam for the treatment of venpadai 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  S Karthika 
Designation  PG scholar 
Affiliation  government siddha medical college and hospital palayamkottai 
Address  Government Siddha Medical College and Hospital Palayamkottai
Government Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  8939283843  
Fax    
Email  drkarthika1993@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  D K Soundararajan 
Designation  HOD 
Affiliation  Government siddha medical college and hospital Palayamkottai 
Address  Government Siddha Medical College and Hospital Palayamkottai
Government Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9442048801  
Fax    
Email  dr.dks2012@gmail.com  
 
Details of Contact Person
Public Query
 
Name  S Karthika 
Designation  PG scholar 
Affiliation  Government siddha medical college and hospital palayamkottai 
Address  Government Siddha Medical College and Hospital Palayamkottai
Government Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  8939283843  
Fax    
Email  drkarthika1993@gmail.com  
 
Source of Monetary or Material Support  
IPD and OPD Government Siddha Medical College and Hospital Palayamkottai Library Government Siddha Medical College and Hospital Palayamkottai 
 
Primary Sponsor  
Name  S karthika 
Address  Government siddha medical college and hospital palayamkottai 
Type of Sponsor  Other [PG Scholar ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
s karthika  Government Siddha Medical College and Hospital  OP NO 7 Post Graduate Department of Kuzhanthai Maruthuvam
Tirunelveli
TAMIL NADU 
8939283843

drkarthika1993@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  patients suffering from venpadai, (1) ICD-10 Condition: L80||Vitiligo,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ilagu seena chooranam  500mg/kg/daily bid orally for 27 days 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body. vitiligo present any part of the body.Patients who are willing to stay in IPD Ward for 27 days or willing to attend OPD. Children who are willing to undergo investigation and give blood and urine samples for laboratory investigation. Patient’s informant / Parent willing to sign the informed consent stating that he/she will consciously stick to the treatment during 27 days but can opt out of the trial of his / her own conscious discretion.
 
 
ExclusionCriteria 
Details  Albinism
Dermatological aspect of leprosy
Tinea versicolor
Burn scars
Dermatological aspect of addisons diseases
Post inflammatory hypopigmentation
Pityriasis alba
Alopecia aerate
chemical leucoderma
white patches on mucous membrane
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The Therapeutic Efficacy of Trial drug Ilaguseena Chooranam on Venpadai
 
27 days 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluation of Siddha Diagnostic Parameters  27 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   27/08/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

STUDY ENROLMENT

 

In this study, patients reporting at the OPD with the clinical symptoms of  patchy loss of skin colour. Premature whitening or graying of the hair on scalp, eye lashes, eye brows or beard. loss of colour in the tissues that lines inside the mouth,nose.  Patient will be examined clinically for enrolling in the study based on inclusion and exclusion criteria.The patients who are to be enrolled patients would be informed (Form IV) about the study, trial drug, possible outcomes and the objectives of the study in the language and terms understandable to them and to their informants.  After ascertaining the parent’s willingness, informed consent would be obtained in writing from them in the consent form (Form IV-A).  All these patients will be given unique registration card in which patient’s registration number of the study address, phone number and Doctor’s phone number etc. will be given, So as to report easily if any complications arise. Complete clinical history, complications and duration, examination findings – all would be recorded in the prescribed proforma in the history and clinical assessment forms separately. Screening form- I   will be filled up; Form I-A, Form II and Form III will be used for recording the patient’s history, clinical examination of symptoms, signs and laboratory investigations respectively. Patients would be advised to take the trial drug and appropriate dietary advice (Form IV-D) would be given according to the patient’s perfect understanding.

 

 

 
Close